Critical Care Research and Practice / 2012 / Article / Fig 2

Clinical Study

Bronchoalveolar Activation of Coagulation and Inhibition of Fibrinolysis during Ventilator-Associated Lung Injury

Figure 2

Bronchoalveolar levels of coagulation and fibrinolysis. Thrombin-antithrombin (TATc), soluble tissue factor (TF), factor VIIa (FVIIa), plasminogen activator activity (PAA) and plasminogen activator inhibitor type 1 (PAI-1) in patients who developed VALI (closed symbols, ), and patients who did not develop VALI (open symbols, ). Data are medians ± IQR. * .

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.